Imagine an automated insulin delivery system that is able to connect with other devices seamlessly. A state-of-the-art, tubeless technology that provides continuous insulin therapy, operates on its own platform and publishes its own communication protocol.
Researchers at Oxford University (UK) are offering powdered insulin to babies at high risk of developing type 1 diabetes (T1D) with the hope of training their immune systems to tolerate the insulin they produce, thereby offering life-long protection against the disease.
JDRF has joined forces with Danish biotech company, Gubra, to develop a glucose-responsive insulin (GRI) as a treatment for people with insulin-dependent diabetes.
JDRF’s leadership was highlighted at the American Diabetes Association’s 78th Scientific Sessions.
How to navigate BBQ season with type 1 diabetes.
For Canadian business, philanthropic efforts are the best way to engage employees and induce positive culture.
Why carbohydrate counting should be explicitly allowed for Disability Tax Credit eligibility. A joint submission with Diabetes Canada.
We’re opening submissions for Kids for a Cure 2018, an exciting advocacy initiative in which JDRF gets youth from across Canada together to impact the future of diabetes research.
Maybe you’ve never heard of the term ‘diabulimia’ before, but this eating disorder affecting people living with type 1 diabetes is more common than you might think.
Great news for Ontario youth! Insulin, diabetes test strips and other prescriptions are now free for Ontarians who are 24 and under.
